www.fdanews.com/articles/69115-illumina-signs-definitive-agreement-to-acquire-cyvera
Illumina Signs Definitive Agreement to Acquire CyVera
February 23, 2005
Illumina has signed a definitive agreement and plan of merger with CyVera, a privately held Connecticut-based company, pursuant to which CyVera will become a wholly owned subsidiary of Illumina. CyVera's digital-microbead platform is highly complementary to Illumina's portfolio of products and services and upon closing of the transaction will become an integral part of the company's BeadArray technology. The acquisition will provide Illumina with a comprehensive approach to bead-based assays for biomarker R&D and in-vitro and molecular diagnostic opportunities, including those that require low-complexity as well as high-complexity testing.
PharmaLive